The percentage of platelet-monocyte coaggregates showed a highly significant decrease by combined anticoagulation with UFH and tirofiban.
← all excerpts
Tirofiban preserves platelet loss during continuous renal replacement therapy in a randomised prospective open-blinded pilot study.
1
—
—